Clinical trial Recruiting at 1 site Observational Ages Any age to 18

AI prediction of complications after transcatheter closure of perimembranous VSD in children

Official title: Multimodal Clinical Data Integration and Artificial Intelligence Modeling for Predicting Complications Following Pediatric Transcatheter Closure of Perimembranous Ventricular Septal Defect

Run by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · NCT07375602 · Data updated 2026-11-12

This project will try an AI model that combines clinical data, text notes, and images to predict which children undergoing transcatheter closure of perimembranous VSD are at higher risk of treatment-related complications.

More Postoperative Complications trials

Quick facts

Study typeObservational
AgesAny age to 18 Years
SexAll
Enrollment5249 (estimated)
SponsorXinhua Hospital, Shanghai Jiao Tong University School of Medicine
Academic / other
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedFebruary 1, 2026
Main results expectedJune 1, 2027
Study endsDecember 30, 2027
Registry record updatedAugust 5, 2026
Trial IDNCT07375602 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 18 or younger with echocardiographically confirmed perimembranous VSD who underwent transcatheter device closure at the study center and have sufficient clinical records and follow-up data.

Probably not a fit

Children with non-perimembranous or complex VSDs, those with prior surgical or transcatheter VSD repair, or patients lacking adequate clinical records are not expected to benefit from this model.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This retrospective observational project will develop and validate a multimodal artificial intelligence model to predict treatment-related complications after transcatheter device closure for perimembranous ventricular septal defect in children. Researchers will extract demographics, laboratory results, electronic health record text, echocardiography reports, chest radiographs, and electrocardiograms from routine clinical records and use deep learning to pull features from text and images. The model will be trained and validated on cases from a single center with outcomes ascertained within a prespecified follow-up window. The aim is to generate individualized risk estimates that can inform monitoring and clinical decision-making.

Why it matters

Potential benefit: If successful, the model could help clinicians identify higher-risk children before or after device closure so monitoring and care can be tailored to reduce complications.

How similar studies have gone: AI approaches have shown promise for cardiac imaging and outcome prediction in related settings, but multimodal deep-learning models specifically for predicting complications after pediatric pmVSD device closure are largely novel and limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≤ 18 years at the time of transcatheter procedure.
* Diagnosis of perimembranous ventricular septal defect confirmed by echocardiography, and underwent transcatheter device closure at the study center.
* Medical records sufficient to ascertain the primary outcome within the pre-specified follow-up window, and availability of minimum baseline clinical information required for model development/validation.

Exclusion Criteria:

* Ventricular septal defects not classified as perimembranous on echocardiography, including muscular, outlet, or inlet VSDs, as well as multiple or complex VSDs involving more than one septal region.
* Presence of complex congenital heart disease or associated structural abnormalities requiring concomitant surgical repair (e.g., tetralogy of Fallot).
* Prior surgical VSD repair or prior transcatheter VSD closure.

Where it's running

  • Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
    Shanghai, Shanghai Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.